Downregulation of cyclin D1 sensitizes cancer cells to MDM2 antagonist Nutlin-3

被引：0
|
作者：
Ou, Wenbin [1 ]
Chen, Weicai [1 ]
Zhu, Jiaqing [1 ]
Eilers, Grant [2 ]
Li, Xuhui [3 ]
Yang, Peipei [1 ]
Li, Hailong [3 ]
Meng, Fanguo [3 ]
Fletcher, Jonathan [2 ]
机构：
[1] Zhejiang Sci Tech Univ, Hangzhou, Zhejiang, Peoples R China
[2] Brigham & Womens Hosp, Boston, MA 02115 USA
[3] Tsinghua Univ, Yangtze Delta Reg Inst, Jiaxing, Peoples R China
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-2707
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2707
引用
收藏
页数：1
相关论文
共 50 条
  • [41] MYCN sensitizes neuroblastoma to the MDM2-p53 antagonists Nutlin-3 and MI-63
    Gamble, L. D.
    Kees, U. R.
    Tweddle, D. A.
    Lunec, J.
    [J]. ONCOGENE, 2012, 31 (06) : 752 - 763
  • [42] MDM2 Antagonist Nutlin-3 Enhances Bortezomib-Mediated Mitochondrial Apoptosis In TP53-Mutated Mantle Cell Lymphoma
    Tabe, Yoko
    Jin, Linhua
    Kojima, Kensuke
    Zhou, Yixin
    Pittaluga, Stefania
    Konopleva, Marina
    Miida, Takashi
    Raffeld, Mark
    [J]. BLOOD, 2010, 116 (21) : 1599 - 1599
  • [43] MDM2 antagonist Nutlin-3 suppresses the proliferation and differentiation of human pre-osteoclasts through a p53-dependent pathway
    Zauli, Giorgio
    Rimondi, Erika
    Corallini, Federica
    Fadda, Roberto
    Capitani, Silvano
    Secchiero, Paola
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 (10) : 1621 - 1630
  • [44] An iTRAQ Proteomics Screen Reveals the Effects of the MDM2 Binding Ligand Nutlin-3 on Cellular Proteostasis
    Nicholson, Judith
    Neelagandan, Kalainanghi
    Huart, Anne-Sophie
    Ball, Kathryn
    Molloy, Mark P.
    Hupp, Ted
    [J]. JOURNAL OF PROTEOME RESEARCH, 2012, 11 (11) : 5464 - 5478
  • [45] Pharmacological inhibition of WIP1 by GSK2830371 sensitizes AML cells to MDM2 inhibitor Nutlin-3a
    Fontana, Maria Chiara
    Nanni, Jacopo
    Marconi, Giovanni
    Pazzaglia, Martina
    Bocconcelli, Matteo
    Padella, Antonella
    Soverini, Simona
    Iacobucci, Ilaria
    Papayannidis, Cristina
    Ferrari, Anna
    Bochicchio, Maria Teresa
    Imbrogno, Enrica
    Cavo, Michele
    di Rora, Andrea Ghelli Luserna
    Simonetti, Giorgia
    Martinelli, Giovanni
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [46] Rescue of p53 function by MDM2 antagonist, Nutlin-3, enhances the apoptotic synergism between MEK1 inhibitor and arsenic trioxide
    Lunghi, P.
    Mazzera, L.
    Rizzoli, V.
    Bonati, A.
    [J]. EXPERIMENTAL HEMATOLOGY, 2007, 35 (09) : 86 - 86
  • [47] MDM2 antagonist Nutlin-3 enhances bortezomib-mediated mitochondrial apoptosis in TP53-mutated mantle cell lymphoma
    Jin, Linhua
    Tabe, Yoko
    Kojima, Kensuke
    Zhou, Yixin
    Pittaluga, Stefania
    Konopleva, Marina
    Miida, Takashi
    Raffeld, Mark
    [J]. CANCER LETTERS, 2010, 299 (02) : 161 - 170
  • [48] Dual-channel surface plasmon resonance monitoring of intracellular levels of the p53-MDM2 complex and caspase-3 induced by MDM2 antagonist Nutlin-3
    Wu, Ling
    Hu, Yuqing
    He, Yuhan
    Xia, Yonghong
    Lu, Hanwen
    Cao, Zhong
    Yi, Xinyao
    Wang, Jianxiu
    [J]. ANALYST, 2019, 144 (13) : 3959 - 3966
  • [49] MDM2 antagonist Nutlin-3a protects wild-type p53 cancer cells from paclitaxel
    SHEN HongChang
    [J]. Science Bulletin, 2012, (09) : 1007 - 1012
  • [50] MDM2 antagonist Nutlin-3a protects wild-type p53 cancer cells from paclitaxel
    Shen HongChang
    Dong Wei
    Gao DongWei
    Wang GuangHui
    Ma GuoYuan
    Liu Qi
    Du JiaJun
    [J]. CHINESE SCIENCE BULLETIN, 2012, 57 (09): : 1007 - 1012
12345